{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:54:48Z","timestamp":1792979688223,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["28805"],"award-info":[{"award-number":["28805"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04376-2","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:08:24Z","timestamp":1782140904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cell line\u2013dependent effects of \u03b2\u2011estradiol and testosterone on aurora kinases, GATA3, and associated miRNAs in hepatocellular carcinoma models HepG2 and Huh\u20117"],"prefix":"10.1186","volume":"26","author":[{"given":"Taraneh","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnoosh","family":"Farzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-8638","authenticated-orcid":false,"given":"Elham","family":"Bahreini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"1","key":"4376_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12876-025-03863-6","volume":"25","author":"MS Hosseini","year":"2025","unstructured":"Hosseini MS, Barjesteh F, Azedi F, Alipourfard I, Rezaei Z, Bahreini E. Comparative analysis of \u03b2-Estradiol and testosterone on lipid droplet accumulation, and regulatory protein expression in palmitate\/oleate-induced fatty HepG2 cells. BMC Gastroenterol. 2025;25(1):263.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"4376_CR2","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1007\/s00210-024-03019-5","volume":"397","author":"F Barjesteh","year":"2024","unstructured":"Barjesteh F, Heidari-Kalvani N, Alipourfard I, Najafi M, Bahreini E. Testosterone, \u03b2-estradiol, and hepatocellular carcinoma: stimulation or inhibition? A comparative effect analysis on cell cycle, apoptosis, and Wnt signaling of HepG2 cells. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(8):6121\u201333.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"4376_CR3","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00210-023-02767-0","volume":"397","author":"N Heidari-Kalvani","year":"2024","unstructured":"Heidari-Kalvani N, Alizadeh-Fanalou S, Yarahmadi S, Fallah S, Alipourfard I, Farahmandian N, et al. Investigation of the effects of catharanthine and Q10 on Nrf2 and its association with MMP-9, MRP1, and Bcl-2 and apoptosis in a model of hepatocellular carcinoma. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(4):2507\u201322.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"4376_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1023\/A:1023789416385","volume":"22","author":"H Katayama","year":"2003","unstructured":"Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003;22(4):451\u201364.","journal-title":"Cancer Metastasis Rev"},{"key":"4376_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13008-018-0040-6","volume":"13","author":"E Willems","year":"2018","unstructured":"Willems E, Dedobbeleer M, Digregorio M, Lombard A, Lumapat PN, Rogister B. The functional diversity of Aurora kinases: a comprehensive review. Cell Div. 2018;13:7.","journal-title":"Cell Div"},{"issue":"6","key":"4376_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000347021","volume":"84","author":"PY Lee","year":"2013","unstructured":"Lee PY, Chen CL, Lin ZZ, Cheng AL, Chen EI, Whang-Peng J, et al. The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme. Oncology. 2013;84(6):326\u201335.","journal-title":"Oncology"},{"key":"4376_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fcell.2015.00014","volume":"3","author":"M Kitagawa","year":"2015","unstructured":"Kitagawa M, Lee SH. The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis. Front Cell Dev Biol. 2015;3:14.","journal-title":"Front Cell Dev Biol"},{"issue":"5a","key":"4376_CR8","first-page":"3585","volume":"26","author":"A Sistayanarain","year":"2006","unstructured":"Sistayanarain A, Tsuneyama K, Zheng H, Takahashi H, Nomoto K, Cheng C, et al. Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma. Anticancer Res. 2006;26(5a):3585\u201393.","journal-title":"Anticancer Res"},{"issue":"1","key":"4376_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00418-017-1546-8","volume":"148","author":"C Chen","year":"2017","unstructured":"Chen C, Zhang Z, Cui P, Liao Y, Zhang Y, Yao L, et al. Phosphorylation of histone H3 on Ser-10 by Aurora B is essential for chromosome condensation in porcine embryos during the first mitotic division. Histochem Cell Biol. 2017;148(1):73\u201383.","journal-title":"Histochem Cell Biol"},{"issue":"20","key":"4376_CR10","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1128\/MCB.01286-14","volume":"35","author":"A Gonz\u00e1lez-Loyola","year":"2015","unstructured":"Gonz\u00e1lez-Loyola A, Fern\u00e1ndez-Miranda G, Trakala M, Partida D, Samejima K, Ogawa H, et al. Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development. Mol Cell Biol. 2015;35(20):3566\u201378.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4376_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41419-024-07329-7","volume":"16","author":"S Vora","year":"2025","unstructured":"Vora S, Chatterjee S, Andrew A, Kumar RP, Proctor M, Zeng Z, et al. Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells. Cell Death Dis. 2025;16(1):7.","journal-title":"Cell Death Dis"},{"issue":"3","key":"4376_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/ol.2021.12492","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Fang X, Xie G, Zhu J. GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression. Oncol Lett. 2021;21(3):231.","journal-title":"Oncol Lett"},{"issue":"1","key":"4376_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12672-010-0006-x","volume":"1","author":"S Jiang","year":"2010","unstructured":"Jiang S, Katayama H, Wang J, Li SA, Hong Y, Radvanyi L, et al. Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells. Horm Cancer. 2010;1(1):11\u201320.","journal-title":"Horm Cancer"},{"issue":"2","key":"4376_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-014-2867-0","volume":"144","author":"M Hosoda","year":"2014","unstructured":"Hosoda M, Yamamoto M, Nakano K, Hatanaka KC, Takakuwa E, Hatanaka Y, et al. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2014;144(2):249\u201361.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4376_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/CBM-190507","volume":"28","author":"WL Su","year":"2020","unstructured":"Su WL, Chuang SC, Wang YC, Chen LA, Huang JW, Chang WT, et al. Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma. Cancer Biomark. 2020;28(3):341\u201350.","journal-title":"Cancer Biomark"},{"issue":"1","key":"4376_CR16","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3892\/ol.2021.12829","volume":"22","author":"W Cai","year":"2021","unstructured":"Cai W, Ji J, Wu B, Hao K, Ren P, Jin Y, et al. Characterization of the small RNA transcriptomes of cell protrusions and cell bodies of highly metastatic hepatocellular carcinoma cells via RNA sequencing. Oncol Lett. 2021;22(1):568.","journal-title":"Oncol Lett"},{"key":"4376_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12935-020-01440-3","volume":"20","author":"X Sun","year":"2020","unstructured":"Sun X, Qian Y, Wang X, Cao R, Zhang J, Chen W, et al. LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1. Cancer Cell Int. 2020;20:367.","journal-title":"Cancer Cell Int"},{"issue":"25","key":"4376_CR18","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.3748\/wjg.v24.i25.2647","volume":"24","author":"F Vasuri","year":"2018","unstructured":"Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, et al. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World J Gastroenterol. 2018;24(25):2647\u201360.","journal-title":"World J Gastroenterol"},{"issue":"2\u20133","key":"4376_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0304-3835(94)90381-6","volume":"76","author":"MV Blagosklonny","year":"1994","unstructured":"Blagosklonny MV, Neckers LM. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Lett. 1994;76(2\u20133):81\u20136.","journal-title":"Cancer Lett"},{"issue":"20","key":"4376_CR20","first-page":"5323","volume":"47","author":"RR Reddel","year":"1987","unstructured":"Reddel RR, Sutherland RL. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Cancer Res. 1987;47(20):5323\u20139.","journal-title":"Cancer Res"},{"key":"4376_CR21","doi-asserted-by":"crossref","unstructured":"Izquierdo AG, Carreira MC, Rodriguez-Carnero G, Perez-Lois R, Seoane LM, Casanueva FF et al. Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease. Int J Mol Sci. 2022;23(23): 15002.","DOI":"10.3390\/ijms232315002"},{"key":"4376_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1479-5876-12-93","volume":"12","author":"L Shi","year":"2014","unstructured":"Shi L, Feng Y, Lin H, Ma R, Cai X. Role of estrogen in hepatocellular carcinoma: is inflammation the key? J translational Med. 2014;12:93.","journal-title":"J translational Med"},{"key":"4376_CR23","doi-asserted-by":"publisher","first-page":"763539","DOI":"10.3389\/fonc.2021.763539","volume":"11","author":"Y Guo","year":"2021","unstructured":"Guo Y, Wu G, Yi J, Yang Q, Jiang W, Lin S, et al. Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway. Front Oncol. 2021;11:763539.","journal-title":"Front Oncol"},{"key":"4376_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12876-015-0288-0","volume":"15","author":"P Solbach","year":"2015","unstructured":"Solbach P, Potthoff A, Raatschen HJ, Soudah B, Lehmann U, Schneider A, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol. 2015;15:60.","journal-title":"BMC Gastroenterol"},{"key":"4376_CR25","doi-asserted-by":"crossref","unstructured":"Boye A, Osei SA, Brah AS. Therapeutic prospects of sex hormone receptor signaling in hormone-responsive cancers. Volume 180. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2024. p. 117473.","DOI":"10.1016\/j.biopha.2024.117473"},{"issue":"4","key":"4376_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ajg.2025.09.002","volume":"26","author":"S Torabi","year":"2025","unstructured":"Torabi S, Mohammadi Y, Hoseini MS, Rezaei A, Mohammadi A, Bahreini E. Investigating the process of apoptosis in HepG2 cells treated with palmitate, oleate, and palmitate\/oleate combination. Arab J Gastroenterol. 2025;26(4):383\u20139.","journal-title":"Arab J Gastroenterol"},{"issue":"2","key":"4376_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mc.20783","volume":"51","author":"H Kamino","year":"2012","unstructured":"Kamino H, Negishi M. The nuclear receptor constitutive active\/androstane receptor arrests DNA-damaged human hepatocellular carcinoma Huh7 cells at the G2\/M phase. Mol Carcinog. 2012;51(2):206\u201312.","journal-title":"Mol Carcinog"},{"issue":"6suppl","key":"4376_CR28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.21873\/cgp.20422","volume":"20","author":"H Yoon","year":"2023","unstructured":"Yoon H, Lee J, Kwon S, Seo SY, Cho S. (S)-3-(3-Fluoro-4-Methoxybenzyl)-5,6,7-Trimethoxychroman-4-One Suppresses the Proliferation of Huh7 Cells by Up-regulating P21 and Inducing G(2)\/M Phase Arrest. Cancer Genomics Proteomics. 2023;20(6suppl):754\u201362.","journal-title":"Cancer Genomics Proteomics"},{"key":"4376_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fonc.2015.00225","volume":"5","author":"V Krenn","year":"2015","unstructured":"Krenn V, Musacchio A. The Aurora B Kinase in Chromosome Bi-Orientation and Spindle Checkpoint Signaling. Front Oncol. 2015;5:225.","journal-title":"Front Oncol"},{"issue":"2","key":"4376_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10495-006-0571-1","volume":"12","author":"PB Lai","year":"2007","unstructured":"Lai PB, Chi TY, Chen GG. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Apoptosis. 2007;12(2):387\u201393.","journal-title":"Apoptosis"},{"issue":"3","key":"4376_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4291\/wjgp.v14.i3.46","volume":"14","author":"HB Choudhary","year":"2023","unstructured":"Choudhary HB, Mandlik SK, Mandlik DS. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World J Gastrointest pathophysiology. 2023;14(3):46\u201370.","journal-title":"World J Gastrointest pathophysiology"},{"issue":"1","key":"4376_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jhep.2020.07.036","volume":"74","author":"YD Luo","year":"2021","unstructured":"Luo YD, Fang L, Yu HQ, Zhang J, Lin XT, Liu XY, et al. p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma. J Hepatol. 2021;74(1):96\u2013108.","journal-title":"J Hepatol"},{"issue":"8\u20139","key":"4376_CR33","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1002\/jcb.29558","volume":"121","author":"W Peng","year":"2020","unstructured":"Peng W, Dong N, Wu S, Gui D, Ye Z, Wu H, et al. miR-4500 suppresses cell proliferation and migration in bladder cancer via inhibition of STAT3\/CCR7 pathway. J Cell Biochem. 2020;121(8\u20139):3913\u201322.","journal-title":"J Cell Biochem"},{"issue":"3","key":"4376_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/cas.13148","volume":"108","author":"T Sato","year":"2017","unstructured":"Sato T, Shiba-Ishii A, Kim Y, Dai T, Husni RE, Hong J, et al. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma. Cancer Sci. 2017;108(3):536\u201342.","journal-title":"Cancer Sci"},{"issue":"3","key":"4376_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","volume":"76","author":"M Pu","year":"2019","unstructured":"Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y, et al. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci. 2019;76(3):441\u201351.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"4376_CR36","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/ol.2016.5110","volume":"12","author":"L Li","year":"2016","unstructured":"Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12(5):3045\u201350.","journal-title":"Oncol Lett"},{"key":"4376_CR37","doi-asserted-by":"crossref","unstructured":"Moon H, Ro SW. MAPK\/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers (Basel). 2021;13(12):3026.","DOI":"10.3390\/cancers13123026"},{"issue":"1","key":"4376_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li Q, Geng S, Luo H, Wang W, Mo YQ, Luo Q, et al. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduct Target therapy. 2024;9(1):266.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"4376_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41419-025-08348-8","volume":"17","author":"X Zhao","year":"2025","unstructured":"Zhao X, Wang Z, Min L, Cao D, Chu Y, Li C, et al. Targeting MED23 inhibits hepatocellular carcinoma development by suppressing compensatory proliferation and facilitating ROS-mediated cell death. Cell Death Dis. 2025;17(1):131.","journal-title":"Cell Death Dis"},{"key":"4376_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/JHC.S48956","volume":"2","author":"T Kanda","year":"2015","unstructured":"Kanda T, Yokosuka O. The androgen receptor as an emerging target in hepatocellular carcinoma. J hepatocellular carcinoma. 2015;2:91\u20139.","journal-title":"J hepatocellular carcinoma"},{"issue":"2","key":"4376_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2012.03.004","volume":"57","author":"VW Keng","year":"2012","unstructured":"Keng VW, Largaespada DA, Villanueva A. Why men are at higher risk for hepatocellular carcinoma? J Hepatol. 2012;57(2):453\u20134.","journal-title":"J Hepatol"},{"issue":"2","key":"4376_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.phymed.2013.07.012","volume":"21","author":"LA Kelly","year":"2014","unstructured":"Kelly LA, Seidlova-Wuttke D, Wuttke W, O\u2019Leary JJ, Norris LA. Estrogen receptor alpha augments changes in hemostatic gene expression in HepG2 cells treated with estradiol and phytoestrogens. Phytomedicine. 2014;21(2):155\u20138.","journal-title":"Phytomedicine"},{"issue":"2","key":"4376_CR43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jcb.20638","volume":"97","author":"G Yoon","year":"2006","unstructured":"Yoon G, Kim JY, Choi YK, Won YS, Lim IK. Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. J Cell Biochem. 2006;97(2):393\u2013411.","journal-title":"J Cell Biochem"},{"issue":"6","key":"4376_CR44","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/hep.29715","volume":"67","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li XX, Yang Y, Zhang Y, Wang HY, Zheng XFS. Significance and mechanism of androgen receptor overexpression and androgen receptor\/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma. Hepatology. 2018;67(6):2271\u201386.","journal-title":"Hepatology"},{"issue":"1","key":"4376_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41420-025-02781-6","volume":"11","author":"R Khadiullina","year":"2025","unstructured":"Khadiullina R, Chasov V, Gilyazova E, Davletshin D, Mirgayazova R, Mingaleeva R, et al. Cellular activity upregulation of the thermolabile p53 cancer mutant Y220C by small molecule indazole derivatives. Cell death discovery. 2025;11(1):508.","journal-title":"Cell death discovery"},{"issue":"2","key":"4376_CR46","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1186\/bcr2249","volume":"11","author":"J Jacquemier","year":"2009","unstructured":"Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, et al. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer. Breast cancer research: BCR. 2009;11(2):R23.","journal-title":"Breast cancer research: BCR"},{"issue":"3","key":"4376_CR47","doi-asserted-by":"publisher","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harbor Perspect Med. 2016;6(3):a026104.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"4376_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13238-019-00665-x","volume":"11","author":"X Fu","year":"2020","unstructured":"Fu X, Wu S, Li B, Xu Y, Liu J. Functions of p53 in pluripotent stem cells. Protein Cell. 2020;11(1):71\u20138.","journal-title":"Protein Cell"},{"key":"4376_CR49","unstructured":"Aditya SA. Exploring GATA3 Regulatory Mechanisms in Breast Cancer Gene Regulatory Networks. 2025."},{"key":"4376_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mrgentox.2015.05.011","volume":"789\u2013790","author":"J Whitwell","year":"2015","unstructured":"Whitwell J, Smith R, Jenner K, Lyon H, Wood D, Clements J, et al. Relationships between p53 status, apoptosis and induction of micronuclei in different human and mouse cell lines in vitro: Implications for improving existing assays. Mutat Res Genetic Toxicol Environ Mutagen. 2015;789\u2013790:7\u201327.","journal-title":"Mutat Res Genetic Toxicol Environ Mutagen"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04376-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:28:31Z","timestamp":1788395311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04376-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4376"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04376-2","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethics Committee of Iran University of Medical Sciences (IR.IUMS.FMD.REC.1403.119). All cell culture practices adhered to international biosafety guidelines for in vitro studies.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"301"}}